✦ LIBER ✦

A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapy

✍ Scribed by Ahn, Jin Seok; Lee, Ki Hyeong; Sun, Jong-Mu; Park, Keunchil; Kang, Eun-Suk; Cho, Eun Kyung; Lee, Dae Ho; Kim, Sang-We; Lee, Gyeong-Won; Kang, Jin-Hyoung; Lee, Jong-Seok; Lee, Jae-Won; Ahn, Myung-Ju

Book ID: 122530449
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 845 KB
Volume: 82
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.08.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Study of Vandetanib

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Heymach, J. V.; Paz-Ares, L.; De Braud, F.; Sebastian, M.; Stewart, D. J.; Eberh 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB

Phase II Study of Erlotinib for Chemothe

Phase II Study of Erlotinib for Chemotherapy-Naive Patients With Advanced/Metastatic Non–Small-Cell Lung Cancer Who Are Ineligible for Platinum-Doublet Chemotherapy

✍ Dae Ho Lee; Heung Tae Kim; Jong Seok Lee 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 43 KB

Phase II study of docetaxel for advanced

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P-573 Docetaxel-innotecan doublet chemot

P-573 Docetaxel-innotecan doublet chemotherapy as first-line therapy for advanced non-small cell lung cancer: A Phase II study

✍ Shamseddine, A.; Abou-Mourad, Y.; Makarem, J.; Kattan, J.; Farhat, F.; Jalloul, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Phase II study of erlotinib for chemothe

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets

✍ Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Yun Hee Han; Jung-Shin Lee 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 241 KB

Phase II study of gemcitabine plus oxali

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ Cappuzzo, F; Novello, S; De Marinis, F; Franciosi, V; Maur, M; Ceribelli, A; Lor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB